Published in Lancet on November 15, 1975
Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol (1980) 1.98
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Ophthalmoscopic signs of obstructed axoplasmic transport after ocular vascular occlusions. Br J Ophthalmol (1976) 1.59
Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol (2005) 1.20
Cilio-retinal infarction after retinal vein occlusion. Br J Ophthalmol (1976) 1.07
Letter to the editor: partial central retinal artery occlusion offers a unique insight into the ischemic penumbra. Clin Ophthalmol (2011) 1.07
Fundus signs in temporal arteritis. Br J Ophthalmol (1978) 0.95
Retrograde labeling, transduction, and genetic targeting allow cellular analysis of corticospinal motor neurons: implications in health and disease. Front Neuroanat (2014) 0.86
Reappraisal of the retinal cotton-wool spot: a discussion paper. J R Soc Med (1981) 0.83
Morphology of axonal transport abnormalities in primate eyes. Br J Ophthalmol (1981) 0.81
The retinal cotton-wool spot. Br J Ophthalmol (1977) 0.75
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet (2001) 3.06
Fit with finger block. Anaesth Intensive Care (1992) 2.66
Relationship between corneal thickness and measured intraocular pressure in a general ophthalmology clinic. Ophthalmology (1999) 2.48
Waiting times and the patient's charter. BMJ (1994) 1.99
Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol (1980) 1.98
Ocular injuries from boxing. BMJ (1992) 1.79
The role of axoplasmic transport in the pathogenesis of retinal cotton-wool spots. Br J Ophthalmol (1977) 1.62
Ophthalmoscopic signs of obstructed axoplasmic transport after ocular vascular occlusions. Br J Ophthalmol (1976) 1.59
Retinal and epiretinal glia--an immunohistochemical study. Br J Ophthalmol (1984) 1.54
Targeting triple-negative breast cancer: optimising therapeutic outcomes. Ann Oncol (2012) 1.49
Immediate treatment with bicalutamide 150mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostate cancer. Eur Urol (2003) 1.46
VEGF localisation in diabetic retinopathy. Br J Ophthalmol (1998) 1.40
Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol (1985) 1.38
Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol (1984) 1.38
D-ACE surgical sequence for selected bullous retinal detachments. Br J Ophthalmol (1985) 1.37
Deriving temperature and age appropriate heart rate centiles for children with acute infections. Arch Dis Child (2008) 1.35
Indentation microsurgery: internal searching for retinal breaks. Eye (Lond) (1989) 1.32
Rapid B-scanning of the vitreous. Br J Ophthalmol (1977) 1.28
Management of complex retinal detachments by vitrectomy and fluid/silicone exchange. Trans Ophthalmol Soc U K (1982) 1.26
Partial central retinal artery occlusion. Trans Ophthalmol Soc U K (1978) 1.22
Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet (1999) 1.22
Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy. Br J Ophthalmol (1995) 1.20
Late onset vitreoretinal complications of regressed retinopathy of prematurity. Br J Ophthalmol (2004) 1.16
Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab Invest (1998) 1.15
A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res (1996) 1.13
Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye (Lond) (1988) 1.13
Results of closed vitrectomy. Trans Ophthalmol Soc U K (1977) 1.11
Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem (2000) 1.10
Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening. Br J Ophthalmol (1998) 1.10
Entry site neovascularisation after diabetic vitrectomy. Br J Ophthalmol (2000) 1.09
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology Group. Cancer (1993) 1.08
Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol (1999) 1.08
Cilio-retinal infarction after retinal vein occlusion. Br J Ophthalmol (1976) 1.07
Suture needle drainage of subretinal fluid. Br J Ophthalmol (1993) 1.07
Influence of laser photocoagulation for clinically significant diabetic macular oedema (DMO) on short-wavelength and conventional automated perimetry. Diabetologia (1998) 1.07
Epiretinal membranes in vitro. Trans Ophthalmol Soc U K (1983) 1.07
Monitored posterior transcleral drainage of subretinal fluid. Br J Ophthalmol (1985) 1.06
Pars plana vitrectomy for vitreous amyloidosis. Ophthalmology (1987) 1.05
Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br J Ophthalmol (1999) 1.05
Vitrectomy and fluid/silicone-oil exchange for giant retinal tears: results at six months. Br J Ophthalmol (1984) 1.05
Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol (1997) 1.04
Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat (1999) 1.03
Topical analgesia for superficial corneal injuries. J Accid Emerg Med (1996) 1.02
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
Inflammation and the formation of epiretinal membranes. Eye (Lond) (1988) 1.02
Evaluation of CancerChatCanada: a program of online support for Canadians affected by cancer. Curr Oncol (2013) 1.01
Three dimensional analysis of the retinal vasculature using immunofluorescent staining and confocal laser scanning microscopy. Br J Ophthalmol (1996) 1.01
Major depression and cardiac autonomic control. Biol Psychiatry (1997) 1.00
Retinal ischaemia, disc swelling, and axoplasmic transport. Trans Ophthalmol Soc U K (1976) 1.00
Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol (1992) 1.00
Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. Br J Ophthalmol (2008) 0.99
Occlusion of posterior ciliary artery. IV. Electroretinographic studies. Br J Ophthalmol (1972) 0.99
Complications of explants used in retinal detachment surgery. Mod Probl Ophthalmol (1979) 0.99
Posterior non-vascularized proliferative extraretinopathy and peripheral nodular retinal telangiectasis. Trans Ophthalmol Soc U K (1982) 0.98
Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Urology (2001) 0.98
Management of retinal detachment in the Wagner-Stickler syndrome. Trans Ophthalmol Soc U K (1985) 0.98
Removal of silicone oil following diabetic vitrectomy. Br J Ophthalmol (1993) 0.97
Complete embedding and close step-sectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients. Prostate Cancer Prostatic Dis (2002) 0.96
Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun (1994) 0.96
A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol (2013) 0.96
Fundus signs in temporal arteritis. Br J Ophthalmol (1978) 0.95
Giant retinal tears after central vitrectomy. Br J Ophthalmol (1985) 0.95
Assessment of the diurnal variation in central corneal thickness and intraocular pressure for patients with suspected glaucoma. Ophthalmology (2000) 0.95
Vitrectomy for severe diabetic eye disease. Trans Ophthalmol Soc U K (1980) 0.94
Reparative epiretinal fibrosis after diabetic vitrectomy. Trans Ophthalmol Soc U K (1985) 0.94
Hemorrhages after central retinal vein occlusion. Arch Ophthalmol (1978) 0.94
Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J (1994) 0.94
Complete Barrett's excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture. Endoscopy (2011) 0.93
Interleukin 3 and cell cycle progression. J Cell Physiol (1986) 0.92
Axial structure of the heterotypic collagen fibrils of vitreous humour and cartilage. J Mol Biol (2001) 0.92
Fibrillin and the eye. Br J Ophthalmol (2000) 0.92
Vascularised vitreoretinopathy: the role of growth factors. Eye (Lond) (1996) 0.91
Retinal detachment following excimer laser. Br J Ophthalmol (1997) 0.91
IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci (2000) 0.91
Management of retinal detachment following congenital cataract surgery. Trans Ophthalmol Soc U K (1983) 0.91
Psychosocial health care needs assessment of adult cancer patients: a consensus-based guideline. Support Care Cancer (2012) 0.91
Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia (1998) 0.91
Diagnostic ultrasound in ophthalmology. J R Soc Med (1980) 0.91
Collagen fibril organisation in mammalian vitreous by freeze etch/rotary shadowing electron microscopy. Micron (2001) 0.90
Inhibition of microvascular endothelial cell proliferation by vitreous following retinal scatter photocoagulation. Br J Ophthalmol (1990) 0.90
Cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Eur J Med Res (2007) 0.90
Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int (1994) 0.90
Ophthalmology in the post-genomic era. Br J Ophthalmol (1999) 0.89
Inappropriate investigation and management of a retinal vascular occlusion. Eye (Lond) (2005) 0.89
Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol (1994) 0.89
Is it time to call time on the scleral buckle? Br J Ophthalmol (2004) 0.89
Silicone-oil injection during closed microsurgery for diabetic retinal detachment. Graefes Arch Clin Exp Ophthalmol (1986) 0.89
Ultrasonic examination in severe diabetic eye disease. Br J Ophthalmol (1979) 0.88
Effect of varying oxygen concentrations on the proliferation of retinal microvascular cells in vitro. Exp Eye Res (1991) 0.88
Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema. Br J Ophthalmol (2003) 0.87
Ultrasound in pre-vitrectomy assessment. Trans Ophthalmol Soc U K (1977) 0.87
Cilio-retinal arterial circulation in central retinal vein occlusion. Br J Ophthalmol (1975) 0.87
Closed microsurgery in the management of intraocular foreign bodies. Trans Ophthalmol Soc U K (1981) 0.87
Is biopsy necessary to diagnose amyloid in the vitreous? Ophthalmology (1988) 0.87
Hypoxia induces HSP 70 gene expression in human hepatoma (HEP G2) cells. Biochem Mol Biol Int (1995) 0.86
Randomised controlled trial of an integrated versus an optometric low vision rehabilitation service for patients with age-related macular degeneration: study design and methodology. Ophthalmic Physiol Opt (2001) 0.86
Retinal relieving incisions. Eye (Lond) (1987) 0.86
Vitrectomy for vitreous opacification in Fuchs' heterochromic uveitis. Eye (Lond) (2000) 0.86
The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma. Health Technol Assess (2005) 0.85